EP 1061952 A2 20001227 - COMBINATION OF A GABA-A ALPHA 5 INVERSE AGONIST AND AN ACETYLCHOLINESTERASE INHIBITOR
Title (en)
COMBINATION OF A GABA-A ALPHA 5 INVERSE AGONIST AND AN ACETYLCHOLINESTERASE INHIBITOR
Title (de)
KOMBINATION VON INVERSE AGONISTEN DES GABA-A ALPHA-5 REZEPTOR SUBTYPS UND ACETYLCHOLINESTERASE-INHIBITOREN
Title (fr)
COMBINAISON D'UN AGONISTE INVERSE ALPHA 5 GABA-A ET INHIBITEUR D'ACETYLCHOLINESTERASE
Publication
Application
Priority
- GB 9900778 W 19990316
- GB 9805561 A 19980316
Abstract (en)
[origin: WO9947131A2] The present invention relates to a combination of an acetylcholinesterase inhibitor and an inverse agonist of the GABAA alpha 5 receptor subtype, and the use of the combination in treating neurodegenerative conditions such as Alzheimer's Disease.
IPC 1-7
IPC 8 full level
A61K 31/50 (2006.01); A61K 31/5025 (2006.01); A61K 45/06 (2006.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01)
CPC (source: EP)
A61K 31/50 (2013.01); A61K 45/06 (2013.01); A61P 25/00 (2017.12); A61P 25/28 (2017.12)
Citation (search report)
See references of WO 9947131A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9947131 A2 19990923; WO 9947131 A3 19991104; AU 2846499 A 19991011; AU 753077 B2 20021010; CA 2323618 A1 19990923; EP 1061952 A2 20001227; GB 9805561 D0 19980513; JP 2002506815 A 20020305
DOCDB simple family (application)
GB 9900778 W 19990316; AU 2846499 A 19990316; CA 2323618 A 19990316; EP 99909095 A 19990316; GB 9805561 A 19980316; JP 2000536371 A 19990316